Investigators compared RNA‐based (RT‐qPCR) and DNA‐based (droplet digital PCR [ddPCR] and Next‐Generation Sequencing [NGS]) methods for measuring residual disease in NPM1‐mutated AML [4]. Here, NPM1 is linked to acute myeloid leukemia.